ElevateBio

ElevateBio is a privately-held, revenue-generating biotech company that operates as an integrated technology and manufacturing partner for the cell and gene therapy industry. The company's unique model combines its proprietary Life Edit gene editing platform—featuring one of the world's largest gene editing toolboxes—with the scalable cGMP manufacturing and process development expertise of its BaseCamp business. This dual approach allows ElevateBio to support partners from concept through commercialization while also advancing its own pipeline of genetic medicines. The company has achieved six consecutive years of revenue growth, driven by expansion of its partner-focused services and technology platforms.

Integrated gene editing (Life Edit) and manufacturing (BaseCamp) platform. Life Edit features one of the world's largest gene editing toolboxes with novel nucleases, base editors, and RNA-guided systems, augmented by AI-driven design and a proprietary LNP delivery platform.

ElevateBio competes in two converging arenas: as a CDMO against giants like Lonza, Catalent, and Thermo Fisher; and as a gene editing technology provider against CRISPR Therapeutics, Intellia, and Beam. Its differentiated integrated model, combining proprietary tools with end-to-end manufacturing, sets it apart from most competitors who operate in only one segment.